A nurse is caring for a client who has chronic glomerulonephritis and has developed metabolic acidosis. Which of the following medications should the nurse expect to administer?

A) "Limit fluids that contain electrolytes":
For a client with gastroenteritis, it is crucial to maintain hydration due to the risk of dehydration from diarrhea and vomiting. However, fluids containing electrolytes can help replenish lost electrolytes and are beneficial. The instruction to "limit" these fluids might be misunderstood as a need to avoid them, which is not appropriate. The aim should be to encourage adequate hydration with fluids that contain electrolytes.

B) "Eliminate sources of probiotics from the diet":
Probiotics can help restore the balance of gut bacteria and may be beneficial in managing gastroenteritis. Eliminating probiotics from the diet is not typically recommended and may not support the recovery process.

C) "Take docusate sodium twice daily":
Docusate sodium is a stool softener, generally used to relieve constipation. In the context of gastroenteritis, which typically involves diarrhea, this medication is not appropriate and could worsen the condition.

D) "Avoid foods high in simple sugars":
Foods high in simple sugars can exacerbate diarrhea by increasing osmotic load in the intestines, leading to more water being drawn into the gut. Avoiding these foods can help manage and reduce symptoms of gastroenteritis.

A) "Monitor for manifestations of hypoglycemia":
Glipizide is a sulfonylurea, which works by increasing insulin secretion from the pancreas. This can lower blood glucose levels, potentially leading to hypoglycemia. Therefore, it's essential for the client to be aware of and monitor for symptoms such as sweating, shakiness, confusion, and dizziness to manage and treat hypoglycemia promptly.

B) "Take this medication at bedtime":
Glipizide is typically taken before meals to stimulate insulin secretion in response to food intake, helping control postprandial blood glucose levels. Taking it at bedtime is not recommended as it might not be as effective and could increase the risk of nighttime hypoglycemia.

C) "Weigh yourself weekly to monitor for weight loss":
While weight monitoring is important for managing diabetes, glipizide does not commonly cause weight loss. In fact, it may sometimes lead to weight gain. Therefore, this instruction is less relevant than monitoring for hypoglycemia.

D) "Plan to continue to take over-the-counter medications as needed":
Over-the-counter medications can interact with glipizide, potentially affecting blood glucose levels or increasing the risk of side effects. The client should consult with their healthcare provider before taking any new medications. This instruction does not address the primary concern of hypoglycemia management.